statin: Clinical Trials

100 trials of statin, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

51 completed, 23 unknown, 11 terminated, 10 recruiting. 24 Phase 4, 19 Phase 2, 17 Not applicable, 14 Phase 3, 4 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 424Completed 9, Unknown 8, Recruiting 3, Terminated 3, Withdrawn 1
Phase 219Unknown 9, Completed 8, Terminated 2
Not applicable17Completed 9, Unknown 4, Withdrawn 2, Not yet recruiting 1, Terminated 1
Phase 314Completed 8, Unknown 4, Terminated 2
Phase 14Completed 1, Recruiting 1, Terminated 1, Unknown 1
Early Phase 11Completed 1

Follow statin: new trials by email Literature Review of statin trials Research Report on statin

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effects of Short-term Intensive Statin Therapy on Lipid Levels
statin - Ischemic Stroke
RecruitingGeneral Hospital of Shenyang Military Region8002026-01-082026-01-15
PCSK9 Inhibitor With Statin Therapy for Asymptomatic Intracranial Atherosclerosis
Recaticimab and Statin, Statin - Intracranial Atherosclerosis, Intracranial Artery Stenosis
Phase 4RecruitingPeking Union Medical College Hospital3002025-11-072026-06-12
Effects of Statins and Hormone Replacement Therapy in Coagulation Profile of Menopausal Women With Dyslipidemia
estroprogestins, Statin - Menopausal Complaints, Hypercholerolemia
RecruitingUniversity of Pisa702025-10-152026-08-03
Protective Effect of PCSK9 Inhibitor Against Negative Inflammatory Response and Organ Dysfunction After Coronary Artery Bypass Grafting (PANDA VIII)
PCSK9 inhibitor, Statin - Myocardial Ischaemic Syndrome, Coronary Heart Disease
Not applicableNot yet recruitingNanjing Medical University4002025-01-012024-12-12
Multicenter Real-World Cohort Study Evaluating the Impact of Early Intensive Lipid-Lowering Therapy on the Prognosis of Acute Coronary Syndrome Patients(ELITE-ACS)
PCSK9 inhibitor, Statin+Ezetimibe/Hybutimibe compound, Statin - Acute Coronary Syndromes
RecruitingYun Dai Chen60002024-12-162025-03-17
Statins in Frail Older Patients with Ischemic Stroke or Transient Ischemic Attack - the Prospective Cohort Study
Statin - Ischemic Stroke, TIA
RecruitingAcademisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)3002024-11-012025-01-21
Efficacy of Probucol Combined with Statins Treatment for Ischemic Stroke
Statin, Probucol - Ischemic Stroke, Atherosclerosis of Artery
RecruitingXuanwu Hospital, Beijing2002024-10-172025-03-25
Statins Effect on Incidence of Side Effects of Platinum Based Chemotherapy
Statin - Solid Tumors, Ototoxicity
Phase 1 / Phase 2CompletedMinia University562024-09-012026-01-20
Effect of SLC01B1 (rs4149956) Polymorphism on the Efficacy and Tolerability of Atorvastatin in Pakistani Population
Atorvastatin - Hyperlipidemias
CompletedRiphah International University1502024-09-012025-08-29
Effect of PCSK9 Inhibitors on Coronary Atherosclerotic Plaques Derived From Optical Coherence Tomography
PCSK9 inhibitor, Statin - Coronary Artery Disease, Optical Coherence Tomography
Phase 4RecruitingFirst Affiliated Hospital of Xinjiang Medical University3962024-07-012024-08-19
An Exploratory Clinical Study of Statins for Improving Chemotherapy and Maintenance in Patients With Ovarian Cancer
Statin, Sugar pill - Ovarian Cancer
Phase 2UnknownAnhui Provincial Cancer Hospital5002024-06-302024-06-21
AdLip: Human Coach-supported Digital/AI Personal Health Assistant to Improve Adherence to Lipid-Lowering Medication
Human Coach-supported Digital/AI Personal Health Assistant to Improve Adherence to Lipid-Lowering Medications - Hyperlipidemia, Medication Nonadherence
Not applicableUnknownNational University of Singapore4502024-06-102024-10-03
Aggressive Risk-Prevention Therapies for Coronary Atherosclerotic Plaque (ART-CAP)
Statin, Aspirin tablet, Nexlizet - Coronary Artery Disease, Atherosclerosis
Phase 4WithdrawnUniversity of Louisville2024-03-012025-03-17
Adjunctive Role of Statin Therapy on Airway Inflammation and Clinical Consequences of Chronic Obstructive Pulmonary Disease
Statin, placepo intervention - Statin, Airway Disease
Not applicableCompletedMohamed Salah El-Sayed802024-01-012026-04-24
Early Initiation of Tafolecimab for Patients With Acute Coronary Syndromeundergoing Percutaneous Coronary Intervention in Chinese Population
Tafolecimab, Cholesterol Absorption Inhibitor, Statin - Acute Coronary Syndrome, Non ST Segment Elevation Acute Coronary Syndrome
Phase 4RecruitingChina National Center for Cardiovascular Diseases36842023-11-112026-10-27
Study on the Composite Endpoint Event of PCSK9 Inhibitor in Patients With Very High Risk of ASCVD and Cancer
Evolocumab, Statin - ASCVD, Atherosclerotic Cardiovascular Disease
Phase 4UnknownXiang Xie6202023-08-012023-08-04
Oral Statins and Protection From Hearing Loss
Statin, methylprednisolone, dexamethasone - Sudden Sensorineural Hearing Loss
Phase 4TerminatedNorthwestern University32023-02-092026-10-29
High Risk Population of Cardiovascular Disease in Hubei Province Screening and Intervention Program
phone calls and encouraging patients' lifestyle change and medication adherence, Statin - Cardiovascular Diseases, Diabetes Mellitus, Type 2
Not applicableUnknownUnion Hospital, Tongji Medical College, Huazhong University of Science and Technology160002023-01-152023-12-15
Effect of Evolocumab on Chronic Total Occlusions (EVOLO-CTO)
PCSK9 inhibitor, Statin - In-stent Restenosis, Major Adverse Cardiovascular Events
Phase 4UnknownLin Zhao2002022-12-152023-11-13
Vascular Endothelial Dysfunction in Sleep Apnea
Atorvastatin 10mg, Placebo, Continuous Positive Airway Pressure Therapy - Obstructive Sleep Apnea of Adult
Phase 1RecruitingColumbia University1102022-10-032026-02-13

Showing 20 of 100. Sign in to see all of them.

Conditions studied

Hypercholesterolemia (13)  ·  Ischemic Stroke (9)  ·  Myocardial Infarction (8)  ·  Atherosclerosis (7)  ·  Dyslipidemias (7)  ·  Hyperlipidemias (6)  ·  Acute Coronary Syndrome (5)  ·  Cardiovascular Diseases (5)  ·  Coronary Artery Disease (5)  ·  Coronary Disease (5)  ·  Stroke (5)  ·  Hypertension (3)  ·  Neoplasms (3)  ·  Angina Pectoris, Variant (2)  ·  Angina, Unstable (2)

Sponsors

Organon and Co (4)  ·  Columbia University (3)  ·  NYU Langone Health (2)  ·  National Taiwan University Hospital (2)  ·  Peking Union Medical College Hospital (2)  ·  Tongji Hospital (2)  ·  Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan (2)  ·  University of Sao Paulo General Hospital (2)  ·  Yonsei University (2)  ·  Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (1)  ·  Alaa Hassan ElBaz (1)  ·  Albert Einstein Healthcare Network (1)  ·  Alfa Wassermann Tunisia (1)  ·  Anhui Provincial Cancer Hospital (1)  ·  Antalya Training and Research Hospital (1)

Countries

United States (22)  ·  China (21)  ·  Canada (7)  ·  Brazil (5)  ·  Japan (4)  ·  South Korea (4)  ·  Taiwan (4)  ·  Egypt (3)  ·  Netherlands (3)  ·  United Kingdom (3)  ·  Australia (2)  ·  Indonesia (2)  ·  Italy (2)  ·  Spain (2)  ·  Bosnia and Herzegovina (1)

Top investigators

Jeffrey Berger, MD (2)  ·  Masayasu Matsumoto, MD, PhD (2)  ·  Sanja Jelic, MD (2)  ·  Yong Huo, MD (2)  ·  Ahmed Abdel-Galeel, MD (1)  ·  Andrei C Sposito, MD, PhD (1)  ·  Andria Priyana, MD, FIHA (1)  ·  Andy Hau Yan Ho (1)  ·  Andy Khong (1)  ·  Angela F Sunjaya (1)  ·  Anil Bhansali, DM (1)  ·  Annapoorna Kini, MD (1)  ·  Anthony P Sunjaya (1)  ·  Ayman Ibrahem, MD (1)  ·  Behnood Bikdeli, MD, MS (1)

Results publications

PMID 28304224, PMID 12423708, PMID 15811480, PMID 16579514, PMID 17452537, PMID 17548554, PMID 17548555, PMID 17936040, PMID 17975198, PMID 18347202, PMID 18413499, PMID 18452788, PMID 18539753, PMID 18584016, PMID 19101028, PMID 19249441, PMID 19538732, PMID 20298928, PMID 20529243, PMID 21543628, PMID 21899409, PMID 22416821, PMID 23085245, PMID 23583255, PMID 24161333, PMID 24489130, PMID 25221387, PMID 25392936, PMID 25773607, PMID 25913664, PMID 26039521, PMID 26567858, PMID 27490922, PMID 27614801, PMID 27639753, PMID 27846344, PMID 28181260, PMID 29030478, PMID 29037448, PMID 29091568, PMID 29191850, PMID 29653628, PMID 30403574, PMID 31011477, PMID 31035902, PMID 31166599, PMID 31248666, PMID 31262327, PMID 31504418, PMID 31800032

NIH funding

R01HL106041 (2), 2023 (1), R01CA218486 (1), R34HL143279 (1)